A review of the development of type 1 interferon antagonists in SLE
https://pmc.ncbi.nlm.nih.gov/articles/PMC7924012/
Sounds like this is the only interferon antagonist on the market right now.
https://en.wikipedia.org/wiki/Anifrolumab
Don't think anyones got one for IFNg out yet.
You are aware that people with MECFS often lose huge amounts of functioning from covid infections? How are we supposed to protect ourselves if the entire world has given up other than by isolating and masking? I hate it but as a severe person I have no other choice other than expose myself to...
Btw did you have any significant side effects from this? Or feel any better? It's been trialled for long covid in The US but I'm very skeptical it could help.
The smug, naked, paternalistic misogyny of this shit.
And oh look- neurodivergent = silly children who don't understand their own bodies.
Medicine needs a thorough and vigorous shake up. It would be like if police training actively and openly encoraged officers to be racist (rather than doing...
I mean the proof of that would surely be if you and others who raise their NK cells in such a way respond to dara (which I hope you do!). It could be that low NK cells indicate a different pathology that can't be altered by just artifically raising NK cells. I don't know if you're allowed to...
A bit brain fogged right now - So are you saying this supports the idea that people with lower NK cells have the same pathology and are not a different subgroup in that sense. And that the response to dara is tied to NK cells (in a different, opposite way than cyclo?)
Or are you saying it...
Absolutely, I think many people hold these mind body beliefs because it gives them a sense of control.
Incidentally, this also what the current approach of extremely controlling pacing as 'treatment' advice that many clinics give does.
Like, I was given the impression that if I managed my...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.